Insights & Analysis
There’s one constant in healthcare: change. Count on us to break down the trends so you can stay up to date. Follow our take on each piece of this deep, intertwined, and often perplexing industry to find opportunities and practical approaches to move healthcare forward.
Featured Content
Premium Content
Premium Content
Avalere’s Research Team to Present Comparative Effectiveness Research at Cystic Fibrosis Conference
Results from a new Avalere study will be presented Thursday, October 27, at the 30th Annual North American Cystic Fibrosis Conference in Orlando, Florida.
Stakeholders Encourage More Patient Involvement in Value Assessment Process
This summer, the Institute for Clinical and Economic Review (ICER) opened a national call for suggestions on how to improve its value assessment framework. In response, ICER received over 50 comments. On October 4, ICER made 46 of those comment letters public.
Presidential Debate #2: Will They or Won’t They Discuss Healthcare?
While we can't make any promises as to whether or not Clinton or Trump will bring up healthcare in Sunday's town hall, the odds of it happening are looking better.
Everything You Need to Know About Kaine and Pence for the VP Debates
In preparation for tonight's vice presidential debates, we thought that we'd take a look at both candidates' health policy positions in addition to Exchange and Part D data for Virginia and Indiana.
Avalere Analysis on Recently Released 2017 Medicare Advantage Landscape Files
The Centers for Medicare & Medicaid Services (CMS) just released the annual Landscape Files containing data on plan participation, beneficiary premiums, and benefit designs for the 2017 Part D and Medicare Advantage (MA) markets. Avalere offers the following observations on key trends in the MA and Part D programs that are likely to influence the 2017 market.
What Will the Future of Home Health Look Like?
Recently, Avalere partnered with the Alliance for Home Health Quality and Innovation to better understand how home healthcare is currently being used and how it will be used in the future for older Americans and Americans with disabilities.
Top Health Policy Stories of Summer 2016
While we technically have a few weeks of summer left, we decided to take a look back at the stories that were catching people's attention based on our website hits.
Avalere Analysis on MedPAC’s Proposed Part D Reforms to Modify Beneficiary Cost Sharing
Avalere recently analyzed two different Part D policy proposals outlined in The Medicare Payment Advisory Commission (MedPAC) June 2016 report to Congress.
CMS Takes on Risk Adjustment in Latest NBPP Proposal
In late August, CMS released its proposed Notice of Benefit and Payment Parameters (NBPP) for the 2018 plan year.
Quality Report for Rheumatoid Arthritis
Avalere recently analyzed the quality measure landscape for rheumatoid arthritis.
Quality Report for Schizophrenia
Avalere recently analyzed the quality measure landscape for schizophrenia.
The Inpatient Prospective Payment Systems (IPPS) FY 2017 Overview
Last Tuesday, August 2, the Centers for Medicare & Medicaid Services (CMS) released the FY 2017 IPPS final rule
Snapshot of Gubernatorial Elections and Outlooks
Recently, Avalere took a look at the gubernatorial elections happening this year, their outlooks, and where they stand on the Exchanges and the Medicaid expansion.
Costs of Care: Getting the Patient-Clinician Conversation Right
Avalere Supports the Robert Wood Johnson Foundation in Issuing Two Calls for Proposals
Commercial Uncertainty Remains as US Biosimilar Pipeline Matures
With the recent announcement of the U.S. Food and Drug Administration's (FDA) acceptance of a submission for approval of a second biosimilar to Remicade (infliximab), questions remain for biologics manufacturers, payers, prescribers, and others as to how a mature biosimilars pipeline will begin to evolve in the United States and whether a sustainable competitive specialty market will develop.
Key Takeaways from the FasterCures Value Assessment 2.0 Webinar
On June 1, Josh Seidman participated in a panel discussion hosted by FasterCures to discuss Avalere's collaboration with FasterCures to develop a patient-centric value framework.
CORRECTION: Early Analysis Finds 2017 Proposed Exchange Rates Exceed 2016 Increases But Vary Widely By State
Popular low cost options see smaller increases.
Side-by-Side Comparison of Clinton and Trump’s Healthcare Priorities
As we near the July conventions and the November election, the dialogue continues to ramp up on the latest policy proposals from the presumptive presidential nominees - Hillary Clinton and Donald Trump.
The Evolving Role of the Center for Medicare and Medicaid Innovation in Achieving Value-Based Payment Goals
The passage of the Affordable Care Act established the Center for Medicare and Medicaid Innovation (CMMI) to help advance new payment and delivery models.
Medicare Advantage: 2016 National Snapshot
In 2016, more than 18 of 56 million Medicare beneficiaries receive their benefits from Medicare Advantage (MA) plans. MA plans are private managed care organizations that contract with the federal government to coordinate care for Medicare beneficiaries.